Development and physicochemical evaluation of bilayered transdermal patches of Ondansetron hydrochloride
DOI:
https://doi.org/10.56511/JIPBS.2021.v8.i03.pp17-23Abstract
Bilayered transdermal patches for delivery of ondansetron hydrochloride were developed by-using polymers HPMC E15 (2.5 gm) and Eudragit RLPO (0.35gm) for the treatment of chemotherapy-induced nausea and vomiting. Different formulations were prepared by varying the grades of polymers by solvent casting method. Prepared patches were evaluated for physicochemical characteristics, mechanical properties, ex vivo permeation study, etc. Optimum formulation consisted of drug (0.395gm), HPMC E15 (2.5gm), PEG 400 (0.75 mL) and oleic acid (0.25 mL) in primary layer and Eudragit RLPO (0.35gm) and PEG 400 (0.105 mL) in secondary layer. The optimized formulation containing showed 109.1 μg /hr/cm2 linear diffusion of drug, 6.33 kg/mm2 tensile strength and 120.33 folding endurance. Drug and polymers interactions were investigated by FTIR studies. FTIR of ondansetron has shown intense band at 3486.61 cm-1, 2922.38cm-1, and 1651.99 cm-1 corresponding to presence of functional groups such as NH group, C-C-Aromatic group and C-C-Aliphatic group. FT-IR of optimized batch had intense bands at 3498.22 cm-1, 2929.13 cm-1, and 1635.88 cm-1 which indicate no change in the functional groups such as NH group, C-C-Aromatic group, C-C-Aliphatic and confirmed undisturbed structure of ondansetron, which indicate no drug-excipients interaction. Thus, Ondansetron hydrochloride can be effectively formulated as bilayered transdermal patch, and it is possible to achieve adequate physicochemical parameters and desired drug diffusion profile with the optimum combination of polymers
Keywords:
Bilayered transdermal patches, Ex-vivo permeation, Ondansetron hydrochloride.Downloads
References
Pastore MN, Kalia YN, Horstmann M, Roberts MS. Transdermal patches: history, development and pharmacology. Br J Pharmacol . 2015; 172(9): 2179 - 2209.
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, et al. The Concise guide to pharmacology 2013/14: Overview. Br J Pharmacol. 2013; 170 :1449 – 1458.
Krishna KD, Pradip ST, Navin SR. Preparation and Optimization of Fast Dissolving Film of Naratriptan Hydrochloride. Recent Pat Drug Deliv Formul. 2017; 11(2): 124-131.
Can AS, Erdal MS, Gungor S, Ozsoy Y. Optimization and characterization of chitosan films for transdermal delivery o f ondansetron. Molecules. 2013; 18(5):5455 - 5471.
Carlisle J, Stevenson CA. WITHDRAWN: Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2017; 7(7):CD004125.
Malik RK, Malik P, Gulati N, Nagaich U. Fabrication and in vitr o evaluation of mucoadhesive ondansetron hydrochloride beads for the management of emesis in chemotherapy. Int J Pharm Investig . 2013; 3(1):42 - 46. doi:10.4103/2230 - 973X.108962 .
Huddart R, Altman RB, Klein TE. PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics . 2019; 29(4):91 - 97.
Vaidya VM, Manwar JV, Mahajan NM, Sakarkar DM. Design and invitro evaluation of mucoadhesive buccal tablets of terbutaline sulphate. Int J Pharm Tech Res. 2009; 1(3): 588597.
Dhamankar AK, Manwar JV, Kumbhar DD. The Novel Formulation Design of O/of Ketoprofen for Improving Transdermal Absorption. Int J of Pharm Tech Res. 2009; 4(1Suppl): 1449-1457.
Manwar J, Kumbhar DD, Bakal RL, Baviskar S, Manmode R. Response surface based co-optimization of release kinetics and mucoadhesive strength for an oral mucoadhesive tablet of cefixime trihydrate. Bulletin of Faculty of Pharmacy, Cairo University. 2016; 54: 227 – 235.
Manwar JV, Patil SS, Patil B, Jadhao RG, Kumbhar DD, Bakal R. Diclofenac Sodium Loaded Nanosized Ethosomes: An Investigation on Z-Average, Polydispersity and Stability. J Pharm Res. 2017; 1(3): 000115.
Patil SS, Kumbhar DD, Manwar JV, Jadhao RG, Bakal RL, Wakode S. Ultrasound - Assisted Facile Synthesis of Nanostructured Hybrid Vesicle for the Nasal Delivery of Indomethacin: Response Surface Optimization, Microstructure, and Stability. AAPS Pharm Sci Tech. 2019; 20(3):97.
Nimbalwar MG, Upadhye K, Dixit G. Fabrication and evaluation of ritonavir proniosomal transdermal gel as a vesicular drug delivery system. P harmacophore. 2016; 7(2): 82 - 95.
Manmode R, Manwar J, Vohra M, Padgilwar S, Bhajipale N. Effect of preparation method on antioxidant activity of ayurvedic formulation kumaryasava. J Homeop Ayurv Med. 2012; 1:114. doi:10.4172/2167-1206.1000114.
Suroshe RS, Wakade RB, Panchale WA, Sakhare AD, Rathod RR, Pophalkar PB. Development and Characterization of Osmotic D rug Delivery System of Model Drug. World Journal of Pharmaceutical Research. 2018; 7(18): 1158 - 1171.
Kadam CY, Bobade NN, Pophalkar PB, Hole SU, Suroshe RS, Panchale WA. Design and In vitro Characterization of Phase Transition System using Rivastigmine Tartrate for Nasal Drug Delivery System. World Journal of Pharmaceutical Research. 2018; 8(1): 8 15 - 829.
Cho, JR, Van Duong, A, Nguyen, LTT. et al. Design of transdermal matrix patch containing ondansetron. Journal of Pharmaceutical Investigation. 2016; 46: 677 – 684.
Mohd F, Bontha LS, Bontha VK, Vemula SK. Formulation and Evaluation of Transdermal Films of Ondansetron Hydrochloride. MOJ Bioequiv Availab. 2017. 3(4): 00039.
Puri A, Bhattaccharjee SA, Zhang W, et al. Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV. Pharmaceutics. 2019; 11(4):173.
Mikolaszek B, Kazlauske J, Larsson A, Sznitowska M. Controlled drug release by the pore structure in polydimethylsiloxane transdermal patches. Polymers (Basel) . 2020; 12(7):1520.
Pastore MN, Kalia YN, Horstmann M, Roberts MS. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015; 172(9): 2179 - 209.
Furuishi T, et al., Formulation design and evaluation of a transdermal drug delivery system containing a novel eptazocine salt with the Eudragit® E adhesive. Journal of Drug Delivery Science and Technology. 2019; 54: 101289.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Anuja S. Motule, Minakshee G. Nimbalwar, Wrushali A. Panchale, Jagdish V. Manwar, Ravindra L. Bakal, Bhushan R. Gudalwar

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at